课题基金 / 基金详情

Chlamydia pneumoniae persistent infection and its mechanism

Chlamydia pneumoniae persistent infection and its mechanism
肺炎衣原体持续感染及其机制
批准号:
17590391
负责人:
YAMAGUCHI Hiroyuki
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

YAMAGUCHI Hiroyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Current studies have revealed that the obligate intracellular bacterium Chlamydia (Chlamydophila) pneumoniae is associated not only with respiratory diseases, but also with chronic diseases such as atherosclerosis. The detection of the C. pneumoniae DNA or antigen in coronary atherosclerotic plaque and peripheral blood of the patients with cardiovascular diseases has strengthened the likelihood of its possible involvement in the pathogenesis of atherosclerosis. Moreover, several studies indicate that viable C. pneumoniae can be detected in atherosclerotic plaques from patients of advanced age with coronary heart disease by both culture and RT-PCR methods. Our recent studies also showed that viable C. pneumoniae are readily detectable in peripheral blood mononuclear cells (PBMCs) obtained from healthy donors, indicating that the presence of viable bacteria in the blood stream might be a risk factor for the development of atherosclerosis. C. pneumoniae preferentially infects respiratory … More tract epithelial cells as well as macrophages. On the other hand, our previous studies revealed that lymphocyte is another host cell permitting C. pneumoniae infection with a persistent nature. Since lymphocytes are a major immune cell type besides macrophages in the development of atherosclerosis, interaction between lymphocytes and this pathogen may contribute to the pathogenesis of chronic inflammatory diseases associated with C. pneumoniae. We first attempted to assess a possible association between development of diabetes in non-obese diabetic (NOD) mice and dissemination of C. pneumoniae from lung to peripheral blood. By real-time reverse transcription-polymerase chain reaction (RT-PCR) with primers for C. pneumoniae 16S rRNA, following multiple intranasal inoculations,. bacteria in lung were detected in NOD mice with diabetes (38.5 %) as well as ICR mice (40 %), but prevalence of bacteria in NOD mice without diabetes (Pre-diabetic NOD mice and non-diabetic retired NOD mice) was very low (4.8 %).The bacteria were only detected in peripheral blood mononuclear cells (PBMCs) cultured withhydrocortisone of the NOD mice with diabetes (53.8 %). Results of immunostaining with fluorescein isothiocyanate-conjugated anti-chlamydia monoclonal antibody also showed the presence of bacterial antigens m the lungs and the PBMCs judged as positive by the RT-PCR. The results clearly showed that the development of diabetes in NOD mouse appears to be one of critical factors for promoting the dissemination of C. pneumoniae from lung to peripheral blood. Second, we examined a possible alteration of CD3 and CD25 expressions of human lymphocytes [Molt-4 cells and enriched lymphocytes from peripheral blood mononuclear cells (PBMCs)] by C. pneumoniae infection. The expression levels of both molecules of Molt-4 cells were significantly decreased by C. pneumoniae infection. C. pneumoniae clinical isolates also caused the alteration of both expressions of the infected cells. In contrast, C. trachomatis did not cause any alteration of both expressions of Molt-4 cells. Heat-killed bacteria and HEp-2 lysate as mock did not cause any alteration of CD3 expression of lymphocytes. Addition of either NS-398 (Cox-2 inhibitor) or AH-23848 (EP4 prostanoid receptorantagonist) tothe culture abolishedthe alteration of CD3 expression ofthe infected cells. The enhanced prostaglandin E_2 (PGE_2) productions in the culture supernatant of infected cells were also confirmed by competitiveELISA. C. pneumoniae infection of enriched lymphocytesfromPBMCs also causedanalteration of CD3 expression.Thus, C. pneumoniae infection of human lymphocytes induces an alteration of CD3 expression mediated by PGE_2 production. Since CD3 molecule has a major role in the signal transduction following antigen recognitions, such alteration may be involved in C.pneumoniae persistent infection of lymphocytes. Also, we foundthat 2-amino-phenoxazine 3-one (phenoxazine derivate: Phx-3)inhibits C. pneumoniae replication in human monocytic cells as well as epithelial cells, partially depending on the tryptophan-metabolic pathway of host cells. Less
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1099/jmm.0.46660-0
发表时间: 2006-11-01
期刊: JOURNAL OF MEDICAL MICROBIOLOGY
影响因子: 3
作者: [Osaki, Takako, Hanawa, Tomoko, Kamiya, Shigeru]
通讯作者: Kamiya, Shigeru
Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae
肺炎衣原体持续感染淋巴细胞的细胞因子反应
DOI: --
发表时间: 2005
期刊: Current Microbiology 50(In press)
影响因子: --
作者: [Takano, R., Yamaguchi, H., 他]
通讯作者:
Effect of Helicobacter pylori on DNA synthesis of human epithelial cells
幽门螺杆菌对人上皮细胞DNA合成的影响
DOI: --
发表时间: 2005
期刊: Journal of Infection and Chemotherapy 11・6
影响因子: --
作者: [Kazuhiro, Yamamoto, Atsushi Toyoda]
通讯作者: Atsushi Toyoda
DOI: --
发表时间: 2005
期刊: Journal of Infection and Chemotherapy 11・11
影响因子: --
作者: [Tomoyasu, T et al., Isao Watanabe, Osaki Takako, Aosai F., Kazuhiro Yamamoto, Hiroyuki Yamaguchi, Matsushima R. et al., Takano Riho, Takahashi A. et al., Norose K., Kazuhiro Yamamoto, Toyoda Atushi]
通讯作者: Toyoda Atushi
7
    Elucidation of the genetic background of thymic epithelial tumors and its application to personalized treatment
    • 批准号:
      17K16049
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2017
    • 负责人:
      YAMAGUCHI Hiroyuki
    • 依托单位:
    Increasing Complexity of Embedded Systems and Development Organizations
    • 批准号:
      26380533
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2014
    • 负责人:
      YAMAGUCHI Hiroyuki
    • 依托单位:
    A study on the development of effective team management strategies by using of visualization of psychological emegent properties of groups
    • 批准号:
      23330197
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.99万
    • 财政年份:
      2011
    • 负责人:
      YAMAGUCHI Hiroyuki
    • 依托单位:
    Technology and perception in the German philosophical tradition
    • 批准号:
      23520371
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      YAMAGUCHI Hiroyuki
    • 依托单位:
    国内基金
    海外基金
    流感病毒感染T淋巴细胞并致感染细胞异常死亡机制研究
    • 批准号:
      81970010
    • 项目类别:
      面上项目
    • 资助金额:
      56.0万元
    • 批准年份:
      2019
    • 负责人:
      曹彬
    • 依托单位:
    microRNA15a/16-1对B细胞及其介导的炎症性肠病恶性转化的调控研究
    • 批准号:
      81601362
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      17.5万元
    • 批准年份:
      2016
    • 负责人:
      刘荣花
    • 依托单位:
    用识别EBV相关淋巴瘤抗原多肽的T细胞受体做转基因免疫治疗
    • 批准号:
      81041002
    • 项目类别:
      专项基金项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2010
    • 负责人:
      岑溪南
    • 依托单位:
    Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
    • 批准号:
      30760248
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      16.0万元
    • 批准年份:
      2007
    • 负责人:
      周源
    • 依托单位: